Senior

Senior Invitee Executive Named to National Health Information Technology Advisory Board

Senior Invitee Executive Named to National Health Information Technology Advisory Board

– Deven McGraw for a term of 3 years from 2023 – SAN FRANCISCO, December 19, 2022 /PRNewswire/ — Invite (NYSE: NVTA), a leading medical genetics company, announced the appointment by the United States Government Accountability Office (GAO) of Deven McGrawHead of Data Stewardship and Sharing at Invitae, National Health Information Technology Advisory Committee (HITAC). …

Senior Invitee Executive Named to National Health Information Technology Advisory Board Read More »

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans

New leaders to elevate product portfolio, customer-centric business capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the arrival of five senior executives to help further strengthen the company product roadmap and improve …

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans Read More »

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans

Myriad Genetics, Inc. New leaders to elevate product portfolio, customer-centric business capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the arrival of five senior executives to help further strengthen the company product …

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans Read More »